Cardiac Safety Services Market To Reach USD 895.7 Million by 2026
Market Summary
The rising incidences of Cardiovascular disorders, improved technological advances, rising prevalence of heart related diseases, rising geriatric population, new product launches, and strategic collaboration, are key factors contributing to the high CAGR of the Cardiac Safety Services market during the forecast period. Market Size – USD 384.9 Million in 2018, Market Growth - CAGR of 11 % Market Trends– Favorable government funding scenario.
Market Summary Our Approach According to the current analysis of Reports and Data, the global Cardiac Safety Services Market valued at USD 384.9 million in 2018 and is expected to reach USD 895.7 million by the year 2026, at a CAGR of 11%. Cardiac safety is the primary cause of the Clinical trial delay and drug abandonment. Cardiac Safety services are beneficial for monitoring the abnormalities of the heart. There has been a significant rise in the R&D expenditure in the pharmaceutical & biopharmaceutical industry and increased R&D activities. The increase in the number of clinical trials is fuelling the growth of the market. Additionally, the advances of the new technologies in the cardiac services market are offering growth opportunities for players in the market. However, the high expenditure cost of cardiac safety evaluation is hindering the growth of the market. Biotrial (France), Banook Group (France & Canada), Bioclinica (a subsidiary of Cinven, US), Certara L.P. (U.S.), Celerion, Inc. (U.S.), ERT, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Medpace Holdings, Inc. (U.S.), Ncardia AG (Belgium), Richmond Pharmacology (U.K.), PhysioStim (France), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development LLC (U.S.), SGS S.A. (Switzerland), BioTelemetry, Inc. (U.S.), IQVIA (U.S.), OMRON Healthcare, Inc (Japan), Biobeat (U.S.) and InBody USA (U.S.), Microsoft (U.S.) To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/2707
Market Summary Our Approach Product and Services Outlook (Revenue in Million USD; 2017–2024) • ECG/Holter Measurement • Blood Pressure Measurement • Cardiovascular Imaging • Thorough Q.T. Studies • Other Services Applications Outlook (Revenue in Million USD; 2017–2024) • Integrated Services • Standalone Services End Use Outlook (Revenue in Million USD; 2017–2024) • Pharmaceutical Companies • Biopharmaceutical Companies • Contract Research Organizations
Grab Your Report at an Impressive Discount! Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/2707
Market Summary Our Approach Further key findings from the report suggest •
Microsoft had launched Microsoft Hololens; it enables the measurement and visualization of blood flow. Microsoft Hololens do not require any tethering device or any additional hardware. The system includes a front-facing camera, remote imaging photoplethysmography software; it allows the users to view the physiological state of a person by simply looking at them. The blood Flow is measured by just looking at the appearance of the subject.
•
Acoalition of professional societies had developed the AUC (Appropriate use criteria) for cardiac imaging to standardize the cardiac imagining system for patients with congenital heart disease it was developed by the American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography, and the International Society for Adult Congenital Heart Disease, AUC provides guidelines to the clinicians to understand the relative risks and benefits of various cardiovascular procedures it also guidelines to understand the risk tetralogy of Fallot, transposition, or atrial septal defects
•
ERT in the year 2018 had launched a Cardiac Safety Center and is also the first to do it; they offer cardia safety assessment in Phase 1 studies using integrated ECG analysis. They had used the Icardiac Technologies for obtaining a precise ECG data using an ERT Expert technology platform.
Read More @ https://www.reportsanddata.com/report-detail/cardiac-safety-services-market
About OurUs Approach
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com